232 related articles for article (PubMed ID: 19768539)
1. Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats.
Itoh T; Satou T; Nishida S; Tsubaki M; Imano M; Hashimoto S; Ito H
Neurochem Res; 2010 Feb; 35(2):348-55. PubMed ID: 19768539
[TBL] [Abstract][Full Text] [Related]
2. The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury.
Itoh T; Satou T; Nishida S; Tsubaki M; Hashimoto S; Ito H
Neurotox Res; 2009 Nov; 16(4):378-89. PubMed ID: 19590930
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of (-)-epigallocatechin-3-gallate in rats when administered pre- or post-traumatic brain injury.
Itoh T; Tabuchi M; Mizuguchi N; Imano M; Tsubaki M; Nishida S; Hashimoto S; Matsuo K; Nakayama T; Ito A; Munakata H; Satou T
J Neural Transm (Vienna); 2013 May; 120(5):767-83. PubMed ID: 23180302
[TBL] [Abstract][Full Text] [Related]
4. Increased apoptotic neuronal cell death and cognitive impairment at early phase after traumatic brain injury in aged rats.
Itoh T; Imano M; Nishida S; Tsubaki M; Mizuguchi N; Hashimoto S; Ito A; Satou T
Brain Struct Funct; 2013 Jan; 218(1):209-20. PubMed ID: 22374222
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
Ohta M; Higashi Y; Yawata T; Kitahara M; Nobumoto A; Ishida E; Tsuda M; Fujimoto Y; Shimizu K
Brain Res; 2013 Jan; 1490():184-92. PubMed ID: 22982593
[TBL] [Abstract][Full Text] [Related]
6. Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats.
Wang GH; Jiang ZL; Li YC; Li X; Shi H; Gao YQ; Vosler PS; Chen J
J Neurotrauma; 2011 Oct; 28(10):2123-34. PubMed ID: 21732763
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate protects against neuronal cell death and improves cerebral function after traumatic brain injury in rats.
Itoh T; Imano M; Nishida S; Tsubaki M; Hashimoto S; Ito A; Satou T
Neuromolecular Med; 2011 Dec; 13(4):300-9. PubMed ID: 22038400
[TBL] [Abstract][Full Text] [Related]
8. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
Zhang W; Sato K; Hayashi T; Omori N; Nagano I; Kato S; Horiuchi S; Abe K
Neurol Res; 2004 Apr; 26(3):342-8. PubMed ID: 15142331
[TBL] [Abstract][Full Text] [Related]
9. A free radical scavenger, edaravone, attenuates steatosis and cell death via reducing inflammatory cytokine production in rat acute liver injury.
Nakamoto N; Tada S; Kameyama K; Kitamura K; Kurita S; Saito Y; Saito H; Ishii H
Free Radic Res; 2003 Aug; 37(8):849-59. PubMed ID: 14567445
[TBL] [Abstract][Full Text] [Related]
10. Edaravone increases regional cerebral blood flow after traumatic brain injury in mice.
Miyamoto K; Ohtaki H; Dohi K; Tsumuraya T; Nakano H; Kiriyama K; Song D; Aruga T; Shioda S
Acta Neurochir Suppl; 2013; 118():103-9. PubMed ID: 23564113
[TBL] [Abstract][Full Text] [Related]
11. The radical scavenger edaravone improves neurologic function and perihematomal glucose metabolism after acute intracerebral hemorrhage.
Shang H; Cui D; Yang D; Liang S; Zhang W; Zhao W
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):215-22. PubMed ID: 25440340
[TBL] [Abstract][Full Text] [Related]
12. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of edaravone on inner ear barotrauma in the guinea pig.
Maekawa H; Matsunobu T; Tsuda H; Onozato K; Masuda Y; Tanabe T; Shiotani A
Neurochem Int; 2009 Jul; 54(8):513-8. PubMed ID: 19428796
[TBL] [Abstract][Full Text] [Related]
14. Appearance of neural stem cells around the damaged area following traumatic brain injury in aged rats.
Itoh T; Imano M; Nishida S; Tsubaki M; Nakayama T; Mizuguchi N; Yamanaka S; Tabuchi M; Munakata H; Hashimoto S; Ito A; Satou T
J Neural Transm (Vienna); 2013 Mar; 120(3):361-74. PubMed ID: 22955958
[TBL] [Abstract][Full Text] [Related]
15. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina.
Imai S; Inokuchi Y; Nakamura S; Tsuruma K; Shimazawa M; Hara H
Eur J Pharmacol; 2010 Sep; 642(1-3):77-85. PubMed ID: 20553915
[TBL] [Abstract][Full Text] [Related]
17. Pre- and posttreatment with edaravone protects CA1 hippocampus and enhances neurogenesis in the subgranular zone of dentate gyrus after transient global cerebral ischemia in rats.
Lei S; Zhang P; Li W; Gao M; He X; Zheng J; Li X; Wang X; Wang N; Zhang J; Qi C; Lu H; Chen X; Liu Y
ASN Neuro; 2014; 6(6):. PubMed ID: 25388889
[TBL] [Abstract][Full Text] [Related]
18. Edaravone attenuates oxidative stress induced by chronic cerebral hypoperfusion injury: role of ERK/Nrf2/HO-1 signaling pathway.
Zhang D; Xiao Y; Lv P; Teng Z; Dong Y; Qi Q; Liu Z
Neurol Res; 2018 Jan; 40(1):1-10. PubMed ID: 29125058
[TBL] [Abstract][Full Text] [Related]
19. Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage.
Lukic-Panin V; Deguchi K; Yamashita T; Shang J; Zhang X; Tian F; Liu N; Kawai H; Matsuura T; Abe K
Curr Neurovasc Res; 2010 Nov; 7(4):319-29. PubMed ID: 20854248
[TBL] [Abstract][Full Text] [Related]
20. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
